Clinical Trials & Medical Discoveries The most recent news and results from scientific and medical research, covering all aspects of healthcare, including testing, diagnosis, and treatment. Stay up-to-date on the latest medical discoveries and breakthroughs with announcements of new products to be tested, upcoming clinical trials and studies, and newly published results. Also included are updates regarding funding decisions, company performance, and legal news.

Latest

Sep 22, 2017, 15:30 ET MabVax Therapeutics Holdings, Inc. Announces $1.25 Million Registered Direct Offering

MabVax Therapeutics Holdings, Inc. (Nasdaq: MBVX), a clinical-stage biotechnology company focused on the development of antibody-based products to...


Sep 22, 2017, 14:20 ET DelMar Pharmaceuticals Announces Closing Of $10 Million Registered Direct Offering Priced At-The-Market

DelMar Pharmaceuticals, Inc. (NASDAQ: DMPI) ("DelMar" or the "Company"), a biopharmaceutical company focused on the development of new cancer...


Sep 22, 2017, 08:00 ET New Data from CENTAUR Phase 2b Clinical Study Supports Continued Development of Cenicriviroc (CVC) in Ongoing Phase 3 AURORA Trial

Allergan plc (NYSE:AGN) today announced top-line results from new data for the CENTAUR Phase 2b study which supports the anti-fibrotic efficacy and...


Sep 22, 2017, 07:45 ET NUST MISIS Scientists Develop Gold Nanoparticles for Cancer Treatment

A group of NUST MISIS scientists jointly with their colleagues from the Saha Institute of Nuclear Physics (Kolkata, India) have managed to...


Sep 22, 2017, 07:00 ET AbbVie and Bristol-Myers Squibb Announce Clinical Research Collaboration to Evaluate a Therapeutic Regimen in Advanced Solid Tumors

AbbVie (NYSE: ABBV) and Bristol-Myers Squibb Company (NYSE: BMY) today announced a clinical trial collaboration to evaluate the combination of...


Sep 22, 2017, 03:20 ET Natera Selected for Circulating Tumor DNA Study in Bladder Cancer

Natera, Inc., (NASDAQ: NTRA), a global leader in cell-free DNA testing, has entered into a research collaboration with Denmark's Aarhus University...


Sep 22, 2017, 03:20 ET Natera sélectionnée pour une étude sur l'ADN tumoral circulant dans le cadre du cancer de la vessie

L'Université d'Aarhus au Danemark utilisera la technologie d'ADNtc Signatera™ dans le cadre d'une étude longitudinale Natera, Inc., (NASDAQ :...


Sep 22, 2017, 03:20 ET Natera seleccionada para un estudio del ADN tumoral circulante en el cáncer de vejiga

La Universidad de Aarhus en Dinamarca utilizará la tecnología de análisis de ADN tumoral circulante Signatera™ en un estudio longitudinal...


Sep 22, 2017, 03:20 ET Natera für Studie zu Zirkulierender Tumor-DNA bei Blasenkrebs ausgewählt

Dänische Universität Aarhus wird Signatera™ ctDNA-Technologie bei Längsschnittstudie einsetzen Natera, Inc., (NASDAQ: NTRA), ein weltweit...


Sep 21, 2017, 12:14 ET DxTerity Collaborates with City of Hope Medical Center on the Development of a Cancer Genomic Blood Test to Predict Response to Radiation Therapy

DxTerity announced today that it is collaborating with the City of Hope Medical Center on the clinical development of a blood test that could...


Sep 21, 2017, 08:47 ET JDRF Funds Zucara Therapeutics' Approach to Preventing Hypoglycemia in People with Type 1 Diabetes

As Global Biotech Week begins in more than 20 countries, JDRF, the leading organization funding type 1 diabetes (T1D) research, is pleased...


Sep 21, 2017, 08:00 ET Patara Pharma's Phase 2 Study Results for Treatment of Persistent Cough in IPF Patients Published in The Lancet Respiratory Medicine

Patara Pharma, a clinical-stage biopharmaceutical company developing therapeutics that significantly improve the lives of patients with chronic...


Sep 21, 2017, 08:00 ET Audentes Therapeutics Announces Dosing of First Patient in ASPIRO, a Phase 1/2 Clinical Trial of AT132 for the Treatment of X-Linked Myotubular Myopathy

Audentes Therapeutics, Inc. (Nasdaq: BOLD), a biotechnology company focused on developing and commercializing gene therapy products for patients...


Sep 21, 2017, 07:30 ET Provention Bio Announces Licensing Agreements with Janssen for Two Clinical-Stage Immunology Assets

Provention Bio, Inc., a clinical stage biopharmaceutical company dedicated to sourcing, developing and commercializing novel therapeutics aimed at...


Sep 21, 2017, 03:13 ET European Commission Approves Bavencio (avelumab) for Metastatic Merkel Cell Carcinoma

Not intended for UK-based media - First approved immunotherapy for rare and aggressive skin cancer in the European Union, with...


Sep 21, 2017, 02:54 ET Alligator Bioscience to Present ADC-1013 Intratumoral Clinical Phase I Study Results at SITC in November 2017

Alligator Bioscience (Nasdaq Stockholm: ATORX), a biotechnology company developing antibody-based pharmaceuticals for tumor-directed immunotherapy,...


Sep 20, 2017, 18:20 ET Dr. William Li Presenting at First International Rethinking Cancer Meeting at European Cancer Centre Gustave Roussy in Paris, France

The Angiogenesis Foundation announced today its President and Medical Director, Dr. William Li, will present new groundbreaking scientific and...


Sep 20, 2017, 14:01 ET Sanofi and NIH researchers develop "three-in-one" antibodies as a potential breakthrough intervention for HIV/AIDS

In a landmark study published in the journal Science today, researchers produced genetically engineered antibodies with the highest activity and...


Sep 20, 2017, 13:00 ET deCODE Study Reveals an Ancient Achilles Heel in the Human Genome

- The generation of new mutations is a key driver of evolution but also of susceptibility to rare diseases - Fathers pass on...


Sep 20, 2017, 11:16 ET Norgine lanza en Italia LYMPHOSEEK®▼ (99mTc-tilmanocept)

Norgine B.V. anunció hoy el lanzamiento en Italia de LYMPHOSEEK® (technetium Tc 99m tilmanocept). LYMPHOSEEK® es un radiofarmacéutico utilizado...


Sep 20, 2017, 11:03 ET Natera Selected for Circulating Tumor DNA Study in Bladder Cancer

Natera, Inc., (NASDAQ: NTRA), a global leader in cell-free DNA testing, has entered into a research collaboration with Denmark's Aarhus University...


Sep 20, 2017, 10:48 ET Norgine führt LYMPHOSEEK®▼ (99mTc-tilmanocept) in Italien ein

Norgine B.V. hat heute die Einführung von LYMPHOSEEK® (Technetium Tc 99m tilmanocept) in Italien bekanntgegeben. LYMPHOSEEK® ist ein...


Sep 20, 2017, 10:36 ET Norgine lance LYMPHOSEEK®▼ (99mTc-tilmanocept) en Italie

Norgine B.V. a annoncé aujourd'hui le lancement de LYMPHOSEEK® (technetium Tc 99m tilmanocept) en Italie. LYMPHOSEEK® est un produit...


Sep 20, 2017, 10:31 ET New Peer-Reviewed Study Shows Pain Behavioral Health Program Participants Experienced Reductions in Depression Symptoms

AbleTo, Inc., the leading provider of technology-enabled behavioral health solutions proven to improve patient outcomes and lower healthcare costs,...


Sep 20, 2017, 09:02 ET DarioHealth Joins Philips-backed Innovation Hub HighTechXL to Empower More Diabetes Patients to Analyze and Personalize Their Treatment

DarioHealth Corp. (NASDAQ: DRIO), a smart diabetes solution, and HighTechXL, a corporate-backed accelerator based in Eindhoven, The Netherlands,...


Most Viewed